Audentes invests in large-scale gene therapy manufacture 19-Feb-2020 By Ben Hargreaves Audentes augments its in-house production capacity with additional plans for a North Carolina facility.
Astellas in $3bn gene therapy acquisition, highlights manufacturing capabilities 04-Dec-2019 By Ben Hargreaves Astellas agrees deal for Audentes, which has a pipeline of gene therapies and large-scale manufacturing capabilities.